The latest closing stock price for Oncobiologics as of November 20, 2024 is 5.28.
An investor who bought $1,000 worth of Oncobiologics stock at the IPO in 2016 would have $-992 today, roughly -1 times their original investment - a -45.55% compound annual growth rate over 8 years.
The all-time high Oncobiologics stock closing price was 867.20 on September 06, 2016.
The Oncobiologics 52-week high stock price is 12.85, which is 143.4% above the current share price.
The Oncobiologics 52-week low stock price is 4.61, which is 12.7% below the current share price.
The average Oncobiologics stock price for the last 52 weeks is 7.56.
An investor who bought $1,000 worth of Oncobiologics stock at the IPO in 2016 would have $-992 today, roughly -1 times their original investment - a -45.55% compound annual growth rate over 8 years.
The all-time high Oncobiologics stock closing price was 867.20 on September 06, 2016.
The Oncobiologics 52-week high stock price is 12.85, which is 143.4% above the current share price.
The Oncobiologics 52-week low stock price is 4.61, which is 12.7% below the current share price.
The average Oncobiologics stock price for the last 52 weeks is 7.56.